Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors

被引：75

作者：

Gellibert, F. ^{[1
]}

Fouchet, M. -H. ^{[1
]}

Nguyen, V. -L. ^{[1
]}

Wang, R. ^{[2
]}

Krysa, G. ^{[1
]}

de Gouville, A. -C. ^{[1
]}

Huet, S. ^{[1
]}

Dodic, N. ^{[1
]}

机构：

[1] GlaxoSmithKline Inc, F-91951 Les Ulis, France

[2] GlaxoSmithKline Inc, Res Triangle Pk, NC 27703 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 08期

关键词：

Transforming growth factor-beta; ALK5; P38MAP Kinase; Liver fibrosis; I RECEPTOR KINASE; TGF-BETA; FIBROSIS; CANCER;

D O I：

10.1016/j.bmcl.2009.02.087

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Starting from quinazoline 3a, we designed potent and selective ALK5 inhibitors over p38MAP kinase from a rational drug design approach based on co-crystal structures in the human ALK5 kinase domain. The quinazoline 3d exhibited also in vivo activity in an acute rat model of DMN-induced liver fibrosis when administered orally at 5 mg/kg (bid). (c) 2009 Elsevier Ltd. All rights reserved.

引用

页码：2277 / 2281

页数：5

共 50 条

[41] Hybridization-based discovery of novel quinazoline-2-indolinone derivatives as potent and selective PI3Kcz inhibitors
Liu, Changqun
Cao, Yuening
Zuo, Yi
Zhang, Chaozheng
Ren, Senmiao
Zhang, Xin
Wang, Chuanqi
Zeng, Yingjie
Ling, Jie
Liu, Yilan
Chen, Zixian
Cao, Xiujun
Wu, Zhengzhi
Zhang, Chuantao
Lu, Jun
JOURNAL OF ADVANCED RESEARCH, 2025, 68 : 459 - 475
[42] Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors
Mansour, Mai A.
Hassan, Ghaneya S.
Serya, Rabah A. T.
Jaballah, Maiy Y.
Abouzid, Khaled A. M.
BIOORGANIC CHEMISTRY, 2024, 147
[43] Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors
Shi, Lei
Yang, Ying
Li, Zi-Lin
Zhu, Zhen-Wei
Liu, Chang-Hong
Zhu, Hai-Liang
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (04) : 1659 - 1664
[44] Discovery of novel tetrahydroisoquinoline derivatives as potent and selective factor Xa inhibitors
Ueno, H
Yokota, K
Hoshi, JI
Yasue, K
Hayashi, M
Uchida, I
Aisaka, K
Hase, Y
Katoh, S
Cho, H
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (01) : 185 - 189
[45] NOVEL 5-AMINOPYRIMIDINE DERIVATIVES AS POTENT AROMATASE INHIBITORS
YODEN, T
KAWAMINAMI, E
SHIMADA, Y
KUDO, M
ISOMURA, Y
OKADA, M
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 62 - MEDI
[46] Design and Synthesis of Novel Macrocyclic Derivatives as Potent and Selective Cyclin-Dependent Kinase 7 Inhibitors
Niu, Pengpeng
Tao, Yanxin
Lin, Guohao
Xu, Huiqi
Meng, Qingyuan
Yang, Kang
Huang, Weixue
Song, Meiru
Ding, Ke
Ma, Dawei
Fan, Mengyang
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 6099 - 6118
[47] The discovery of novel, potent and selective PDE5 inhibitors
Bi, YZ
Stoy, P
Adam, L
He, B
Krupinski, J
Normandin, D
Pongrac, R
Seliger, L
Watson, A
Macor, JE
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) : 2461 - 2464
[48] Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors: Rational design, synthesis and antiproliferative activity
Chen, Xin
Chen, Xinyang
Steimbach, Raphael R.
Wu, Tong
Li, Hongmei
Dan, Wenjia
Shi, Peidong
Cao, Chenyu
Li, Ding
Miller, Aubry K.
Qiu, Zhixia
Gao, Jinming
Zhu, Yong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 187
[49] Valvular heart lesions in Han Wistar rats dosed with ALK5 inhibitors
Anderton, Mark J.
Heier, Annabelle
Bell, Alex
Sadler, Claire
Pass, Martin
Powell, Steve
Mellor, Howard R.
Roberts, Ruth A.
TOXICOLOGY, 2010, 278 (03) : 343 - 343
[50] Discovery of Quinazoline Derivatives as Potent KRASG12C Inhibitors
Liu, Nian
Li, Zhilong
Liu, Rui
Zhang, Chaoxin
Sun, Yixiang
Ma, Xing
Qin, Qiaohua
Wu, Tianxiao
Sun, Yin
Yin, Wenbo
Zhang, Haoyu
Gao, Zixuan
Xia, Guangxin
Zhao, Dongmei
Cheng, Maosheng
CHEMISTRYSELECT, 2024, 9 (39):

← 1 2 3 4 5 →